The levels of norharman are high enough after smoking to affect monoamineoxidase B in platelets.

@article{Rommelspacher2002TheLO,
  title={The levels of norharman are high enough after smoking to affect monoamineoxidase B in platelets.},
  author={Hans Rommelspacher and Mignon Meier-Henco and Michael Smolka and Charlotte Kloft},
  journal={European journal of pharmacology},
  year={2002},
  volume={441 1-2},
  pages={115-25}
}
Epidemiological studies suggest that smoking reduces the risk for Parkinson's disease. It has been hypothesized that inhibition of monoamineoxidase contributes to this action. The present study examined the contribution of the beta-carbolines norharman, an inhibitor of monoamineoxidase B, and harman, an inhibitor of monoamineoxidase A, which are present in… CONTINUE READING